We’re improving your experience!

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04165083
Title KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | ISR | HUN | ESP

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ( Site 0001) Gilbert Arizona 85234 United States Details
City of Hope ( Site 0014) Duarte California 91010 United States Details
UCSF Medical Center at Mission Bay ( Site 0007) San Francisco California 94158 United States Details
Georgetown University ( Site 0036) Washington District of Columbia 20007 United States Details
University of Kentucky Markey Cancer Center ( Site 0019) Lexington Kentucky 40536-0293 United States Details
MedStar Franklin Square Medical Center ( Site 0033) Baltimore Maryland 21237 United States Details
Massachusetts General Hospital ( Site 0003) Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute ( Site 0002) Boston Massachusetts 02215 United States Details
Oncology Hematology West, PC DBA Nebraska Cancer Specialists ( Site 0031) Omaha Nebraska 68130 United States Details
Dartmouth Hitchcock Medical Center ( Site 0016) Lebanon New Hampshire 03766 United States Details
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0037) Hackensack New Jersey 07601 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0034) New York New York 10016 United States Details
Sanford Fargo Medical Center ( Site 0039) Fargo North Dakota 58102 United States Details
Cleveland Clinic ( Site 0006) Cleveland Ohio 44195 United States Details
Ohio State University Comprehensive Cancer Center ( Site 0015) Columbus Ohio 43210 United States Details
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) Philadelphia Pennsylvania 19104 United States Details
Sanford Cancer Center ( Site 0038) Sioux Falls South Dakota 57104 United States Details
The University of Texas MD Anderson Cancer Center ( Site 0009) Houston Texas 77030 United States Details
Petz Aladar Megyei Oktato Korhaz ( Site 0062) Gyor Gyor-Moson-Sopron 9024 Hungary Details
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 0061) Szolnok Jasz-Nagykun-Szolnok 5000 Hungary Details
Orszagos Koranyi Pulmonologiai Intezet ( Site 0060) Budapest 1121 Hungary Details
Soroka Medical Center ( Site 0072) Beer-Sheva 8457108 Israel Details
Rambam Health Care Campus-Oncology ( Site 0076) Haifa 3109601 Israel Details
Shaare Zedek Medical Center ( Site 0075) Jerusalem 9103102 Israel Details
Meir Medical Center ( Site 0071) Kfar-Saba 4428132 Israel Details
Rabin Medical Center ( Site 0074) Petah Tikva 4941492 Israel Details
Chaim Sheba Medical Center ( Site 0070) Ramat Gan 5262000 Israel Details
Sourasky Medical Center ( Site 0077) Tel Aviv 6423906 Israel Details
Azienda Ospedaliera Universitaria Careggi ( Site 0173) Florence Firenze 50134 Italy Details
Policlinico Gemelli di Roma ( Site 0174) Roma Lazio 00168 Italy Details
IRCCS Ospedale San Raffaele ( Site 0171) Milano 20132 Italy Details
Seoul National University Bundang Hospital ( Site 0081) Seongnam-si Kyonggi-do 13620 Korea, Republic of Details
Severance Hospital ( Site 0080) Seoul 03722 Korea, Republic of Details
Samsung Medical Center ( Site 0082) Seoul 06351 Korea, Republic of Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier Warszawa Mazowieckie 02-781 Poland Details
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150) Gdańsk Pomorskie 80-952 Poland Details
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0152) Koszalin Zachodniopomorskie 75-581 Poland Details
ICO L Hospitalet ( Site 0090) Hospitalet de Llobregat Barcelona 08907 Spain Details
Hospital Universitario Quiron Madrid ( Site 0091) Pozuelo de Alarcon Madrid 28223 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field